Pharmaceutical compositions comprising fatty glycerol esters
View Patent ↗The present invention relates to a pharmaceutical composition comprising glycerol esters of a fatty acid, wherein the compositions are useful for the delivery of anti-psychotic drugs.
1. A pharmaceutical composition consisting of:
(a) compound A-7:
(b) a glycerol ester, wherein the glycerol ester is sesame oil;
(c) an aqueous vehicle selected from the group consisting of sterile water, bacteriostatic water for injection, sterile saline solution, Ringer's solution, dextrose solution, phosphate buffer, citrate buffer, tartrate buffer, and acetate buffer; and
(d) polysorbate 20;
wherein the composition forms an aqueous, flocculated, injectable suspension.
2. The pharmaceutical composition of claim 1 , wherein (a) and (b) are present at a ratio that results in flocs comprising component (a), wherein the flocs settle to a bed height that is greater than the sediment height of a formulation without component (b), such that components (a) and (b) can be resuspended for injection.
3. The pharmaceutical composition of claim 1 , wherein (b) and (d) are present at a ratio that results in flocs of component (a) wherein the flocs settle to a bed height that is greater than the sediment height of a formulation without components (b) and (d), such that components (a), (b) and (d) can be resuspended for injection.
4. The pharmaceutical composition of claim 2 , wherein (a) and (b), and optionally (d), can be resuspended for injection within 1-60 seconds of handshaking.
5. The pharmaceutical composition of claim 2 , wherein the ratio of (a) to (b) and (a), (b) and (d) are such that the composition can be injected using a 20 or greater gauge needle.
6. The pharmaceutical composition of claim 1 , wherein the ratio of (b) to (d) is approximately 0.5-1 to 20 to 1, by weight.
7. The pharmaceutical composition of claim 1 , wherein the concentration of (a) is approximately 5-15 weight percent.
8. An injectable pharmaceutical composition consisting of:
(a) approximately 5-35 weight percent compound A-7:
(b) approximately 0.3-20 weight percent of a glycerol ester, wherein the glycerol ester is sesame oil;
(c) approximately 0-1 weight percent polysorbate 20 and
(d) an aqueous carrier selected from the group consisting of sterile water, bacteriostatic water for injection, sterile saline solution, Ringer's solution, dextrose solution, phosphate buffer, citrate buffer, tartrate buffer, and acetate buffer.
9. A method for treating disorders of the central nervous system, comprising administering an effective amount of the composition of claim 1 to an individual in need of such treatment.
10. A pharmaceutical composition consisting of:
(a) 15-35 weight percent compound A-7:
(b) 0.1-20 weight percent of a glycerol ester, wherein the glycerol ester is sesame oil;
(c) 0.05-1.0 weight percent polysorbate 20; and
(d) an aqueous carrier selected from the group consisting of sterile water, bacteriostatic water for injection, sterile saline solution, Ringer's solution, dextrose solution, phosphate buffer, citrate buffer, tartrate buffer, and acetate buffer.
11. The composition of claim 1 , wherein the sterile saline solution is phosphate-buffered saline.
12. The composition of claim 8 , wherein the sterile saline solution is phosphate-buffered saline.
13. The composition of claim 10 , wherein the sterile saline solution is phosphate-buffered saline.